Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact

BIO Investor Forum

Home / Events / BIO Investor Forum

17Oct 2016 by siwa-admin-2017

copy here

Search for:

About Us

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.

Recent News

In the News: Forbes
SIWA Therapeutics: A New Supernova to Discover!
DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD

JOIN OUR MAILING LIST

Navigation

Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact